Health Services Research
Latest posts by Health Services Research (see all)
- Duration to Admission and Hospital Transfers Affect Facility Rankings from the Postacute 30-Day… - Jun. 28, 2016
- Community Characteristics and Qualified Health Plan Selection during the First Open Enrollment… - Jun. 28, 2016
- Impact of a Pay-for-Performance Program on Care for Black Patients with Hypertension: Important… - Jun. 22, 2016
- Fighting MRSA Infections in Hospital Care: How Organizational Factors Matter - Jun. 22, 2016
Objective To compare the use of guideline-recommended prescription medications for diabetes among Medicare beneficiaries enrolled in stand-alone prescription drug plans (PDPs) with Medicare Advantage prescription drug plans (MAPDs) in the presence of potential selection bias. Data Sources/Study Setting Centers for Medicare and Medicaid Services’ Chronic Condition Data Warehouse (2006, 2007). Study Design Retrospective cross-sectional comparison of drug use and proportion of days covered (PDC) for oral-antidiabetics, ACE-inhibitors/ARBs, and antihyperlipidemics among PDP and MAPD enrollees with diabetes. We estimated nave regression models assuming exogenous plan choice and two-stage residual inclusion (2SRI) models to study endogeneity in choice of Part D plan type.
Originally posted here: